-+ 0.00%
-+ 0.00%
-+ 0.00%

CANDEL THERAPEUTICS INC: PHASE 3 PIVOTAL STUDY PLANNED FOR INITIATION IN Q2 2026

Reuters·03/17/2026 12:12:27

Please log in to view news